RAPT THERAPEUTICS INC (RAPT)

US75382E1091 - Common Stock

1.74  +0.91 (+110.81%)

After market: 1.6602 -0.08 (-4.59%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
5.04M3.81M
-24.40%
1.53M
-59.84%

-100.00%
19.38M106.56M
449.85%
285.02M
167.47%
602.28M
111.31%
447.78M
-25.65%
EBITDA
YoY % growth
-52.09M
-23.14%
-68.21M
-30.95%
-84.75M
-24.25%
-129.458M
-48.49%
-110.191M
12.44%
-83.314M
24.39%
-91.994M
-10.42%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-53.21M
-21.96%
-69.21M
-30.07%
-85.8M
-23.97%
-129.418M
-48.09%
-103.621M
18.45%
-79.646M
23.14%
-84.425M
-6.00%
-297.84M
-252.78%
-210.324M
29.38%
43.248M
120.56%
444.57M
927.96%
289.68M
-34.84%
Operating Margin
-1,055.75%-1,816.54%-5,607.84%N/AN/AN/AN/A-1,536.84%-197.38%15.17%73.81%64.69%
EPS
YoY % growth
-2.19
5.62%
-2.53
-15.53%
-2.58
-1.98%
-3.17
-17.83%
-2.53
16.66%
-1.88
25.93%
-1.10
41.30%
-4.14
-275.93%
-3.37
18.72%
-0.82
75.76%
1.43
275.63%
7.11
396.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.48
40.62%
-0.47
40.61%
-0.47
33.20%
-0.47
-0.37%
-0.46
2.30%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-25.5M
20.31%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-20.518M
38.23%
-22.309M
33.51%
-22.763M
24.75%
-23.037M
13.36%
-23.65M
-15.27%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.47
42.68%
-0.580.1118.30%
Q2 2024
Q2Q % growth
-0.71
-7.58%
-0.730.023.32%
Q1 2024
Q2Q % growth
-0.79
-3.95%
-0.820.034.17%
Q4 2023
Q2Q % growth
-0.80
-25.00%
-0.880.088.68%
Q3 2023
Q2Q % growth
-0.82
-30.16%
-0.77-0.05-6.73%
Q2 2023
Q2Q % growth
-0.66
-6.45%
-0.800.1417.22%
Q1 2023
Q2Q % growth
-0.76
-10.14%
-0.69-0.07-9.57%
Q4 2022
Q2Q % growth
-0.64
-4.92%
-0.670.034.06%
Q3 2022
Q2Q % growth
-0.63 -0.680.057.81%
Q2 2022
Q2Q % growth
-0.62
1.59%
-0.770.1518.95%
Q1 2022
Q2Q % growth
-0.69
-4.55%
-0.690.000.34%
Q4 2021
Q2Q % growth
-0.61
-17.31%
-0.670.068.99%
Q3 2021
Q2Q % growth
-0.63
-5.00%
-0.640.010.84%
Q2 2021
Q2Q % growth
-0.63
-23.53%
-0.680.057.54%
Q1 2021
Q2Q % growth
-0.66
-17.86%
-0.64-0.02-3.70%
Q4 2020
Q2Q % growth
-0.52
36.59%
-0.610.0914.08%
Q3 2020
Q2Q % growth
-0.60
95.17%
-0.59-0.01-2.30%
Q2 2020
Q2Q % growth
-0.51 -0.590.0813.30%
Q1 2020
Q2Q % growth
-0.56 -0.44-0.12-27.68%
Q4 2019
Q2Q % growth
-0.82 -0.71-0.11-15.67%
Q3 2019
Q2Q % growth
-12.41 -0.65-11.76-1,801.04%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth

-100.00%
221.003K-221.003K-100.00%
Q3 2022
Q2Q % growth

-100.00%
343.883K-343.883K-100.00%
Q2 2022
Q2Q % growth
890K
2.30%
285.6K604.4K211.62%
Q1 2022
Q2Q % growth
640K
-47.54%
229.5K410.5K178.87%
Q4 2021
Q2Q % growth
760K
-41.54%
709.624K50.376K7.10%
Q3 2021
Q2Q % growth
970K
-36.60%
793.897K176.103K22.18%
Q2 2021
Q2Q % growth
870K
-32.03%
969K-99K-10.22%
Q1 2021
Q2Q % growth
1.22M
29.79%
926.16K293.84K31.73%
Q4 2020
Q2Q % growth
1.3M 1.302M-2K-0.15%
Q3 2020
Q2Q % growth
1.53M 1.021M509K49.85%
Q2 2020
Q2Q % growth
1.28M 1.005M275K27.36%
Q1 2020
Q2Q % growth
940K 4.25M-3.31M-77.88%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 2.2% 1.28%
RevenueN/A N/A N/A N/A